In this controlled prospective study, 14 patients with cervical intraepithelial neoplasia (CIN) were observed for one month to exclude spontaneous regression, and then seven patients were treated twice-weekly with perilesional injections of a-interferon. Both groups were monitored colposcopically, and advised to use the contraceptive sheath. Cervical smears and biopsies for histology and viral studies were taken before and after the study.
Introduction
Treatment of CIN is performed by destructive methods (laser, cold coagulation, cryocautery) or excision (by cone biopsy or loop diathermy). In some circumstances, such as recurrence of CIN in the vaginal stump after hysterectomy, such methods may be hazardous or incomplete. It was therefore decided to investigate the use of o-interferon injections around areas of CIN to see whether these would cure the lesions, either by antiviral or antineoplastic action of o-interferon, or both.
One study! from Hong Kong used perilesional injections of o-interferon to treat CIN, and produced remission in six out of seven patients. However, in this trial CIN was not confirmed independently by biopsy before treatment, and there were no controls. In the present trial pre-treatment biopsies were taken to confirm CIN, but were followed by a waiting period of a month to exclude spontaneous cure due to trauma'', Controls were also included.
Finally, biopsies for identification ofHPV 6+16,3,4 were taken to see ifthere was any correlation between these viruses, CIN, and o-interferon treatment.
Subjects and methods
Fourteen patients who had been referred to the colposcopy clinic with abnormal smears and had a colpobiopsy confirming CIN were recruited into the trial. Smears had already been taken, and in addition a biopsy of the abnormal area for HPV 6+ 16 hybridization were obtained. Full blood count and liver function tests were performed before the trial and after a-interferon treatment in the trial group.
After a month's waiting period, a colposcopic assessment excluded spontaneous regression, and the patients were assigned to the study or control groups.
The study patients were colposcoped twice weekly, and 1.5 Mu of o-interferon CIntron A) was injected through a 22 gauge needle at three or four sites peripheral to the lesion at a depth of 0.5 cm. The control group were observed colposcopically for 8 weeks.
After 8 weeks the groups had a complete review:
repeat smear and colpobiopsies for histology and virology were taken. In cases where complete cure had not been achieved over the study period of 12 weeks, laser ablation was performed. In this way the trial patients experienced no delay in the hospital's routine treatment for CIN by laser after a maximum 12 weeks' waiting list.
Histological and cytological reassessment was made by an independent histologist who had no knowledge of which subjects were in the treatment and nontreatment groups.
Biopsies for HPV hybridization were immediately frozen in liquid nitrogen and thawed in batches for DNA analysis for HPV types 6+ 16.
Results
Six out of seven patients in the a-interferon treatment group showed improvement of histology over the treatment period (Table 1) , whereas only three of the control group showed improvement, and one showed deterioration (Table 2) . Six out of seven of the ainterferon group showed cytological improvement, whereas only two of the control group showed improvement, and one had deteriorated.
There were two 'cures' in the o-interferon group (complete histological and cytological recovery). There also was a disappearance ofkoilocytosis histologically and cytologically in all 4 o-interferon-treated patients who showed koilocytosis before treatment.
No HPV type 6 was isolated from the patients. HPV 16 was isolated in three patients from the study group and two controls and later appeared in a third control patient. It disappeared after treatment in the three patients on the a-interferon group, but also spontaneously from two controls. Its presence was not isolated with a more severe lesion, and it was associated with an average response to interferon (one cure and two 'improved', see Table 1 ).
Colposcopic changes during treatment were of hyperaemia of the cervix lasting 2 weeks and initial gradual paling of acetowhite and contraction of the lesion. There was an initial dramatic regression of a cervical wart, which later partially recurred. Unexpectedly, a new focus of dysplasia developed in an area of transformation zone not being treated by a-interferon in one patient, whereas the treated area regressed completely.
Discussion
The results of this study support the findings of Choo et al.! that a-interferon injections cause improvement or cure in CIN lesions, although both studies have been small. Our results do not show such a dramatic cure rate (two out of seven, as opposed to six out of seven) but both studies showed improvement in all cases, using interferon. It is possiblethat improvement in administration of a-interferon may improve results, eg injection at the centre of the lesion might be better than at the periphery, where centrifugal drainage tends to diminish the concentrations of a-interferon most rapidly. Also, injections are painful and delivery by topical application would be preferable, if effective. Byrne et al. 5 have tried topical a-interferon gel with disappointing results. This may be because gel does not penetrate deeply enough into cervical tissue. One of the authors (AD) has therefore treated CIN with a-interferon mixed with dimethysulphoxide (DMSO) a penetrating agent, (unpublished case study), but this proved ineffective. The incidental finding of the development of a new area of dysplasia in a part of the transformation zone not being treated with a-interferon demonstrated that there is likely to be heightened potential for malignant change in the whole ofthe transformation zoneat the time of development of CIN in any part of it, and supports the current practice of treating the whole transformation zone when CIN occupiesany part of it.
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